FundedIQ
Biotechnology

Civatech Oncology: Funding, Investors & Team (Oct 2026)

Civatech Oncology is a healthcare equipment company that creates devices made from polymers to combat cancer through localized radiation therapy with a low dose rate. The advantage of using polymers is their versatility in manufacturing various shapes and structures, allowing CivaTech to design and produce devices specifically tailored to different types of tumors. Their initial product, the CivaString, has received clearance from the FDA to treat all solid tumor types. Established in 2006, the company is headquartered in Durham, North Carolina, in the United States.

www.civatechoncology.com LinkedIn Durham, United States 1-10 employees
Biotechnology Life Science Pharmaceutical
Total raised
$4.0M
Rounds
1
Latest
Undisclosed round
Aug 2023

Civatech Oncology has raised $4.0M across 1 funding round on record, the most recent an undisclosed round of $4.0M announced in Aug 2023.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Civatech Oncology Company Profile and Key Stats

Total funding raised
$4.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$4.0M in Aug 2023
Employees
1-10
reported band
Headquarters
Durham, United States

Latest funding round on record: Aug 2023.

Civatech Oncology Funding Rounds

Date
Round
Amount
Undisclosed round
$4.0M

Civatech Oncology Founders and Leadership Team

Name
Role
Contact
Suzanne Troxler Babcock
Founder
—

No contact details are on record for this team yet.

Civatech Oncology Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Civatech Oncology's latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Civatech Oncology in Biotechnology and Durham

Companies Similar to Civatech Oncology

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Civatech Oncology Funding FAQs

What does Civatech Oncology do?

Civatech Oncology is a healthcare equipment company that creates devices made from polymers to combat cancer through localized radiation therapy with a low dose rate. The advantage of using polymers is their versatility in manufacturing various shapes and structures, allowing CivaTech to design and produce devices specifically tailored to different types of tumors. Their initial product, the CivaString, has received clearance from the FDA to treat all solid tumor types. Established in 2006, the company is headquartered in Durham, North Carolina, in the United States.

How much funding has Civatech Oncology raised?

Civatech Oncology has raised $4.0M across 1 round on record. The most recent is an undisclosed round of $4.0M announced in Aug 2023.

When did Civatech Oncology last raise funding?

Civatech Oncology's most recent funding round on record is an undisclosed round of $4.0M, announced in Aug 2023.

Who founded Civatech Oncology?

FundedIQ lists Suzanne Troxler Babcock (Founder) at Civatech Oncology.

Where is Civatech Oncology headquartered?

Civatech Oncology is based in Durham, North Carolina, United States.

How many employees does Civatech Oncology have?

Civatech Oncology is in the 1-10 employee band.

How does Civatech Oncology's funding compare to other Biotechnology startups?

Civatech Oncology's latest round of $4.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Civatech Oncology Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Civatech Oncology is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.